Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 8-K Event Material agreement
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4 Open-market buy Chief Financial Officer bought 1,250 shares at $20.03 ($25,037)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Executive or director change · Shareholder vote results · Regulation FD disclosure
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. ARS Other Annual Report to Security Holders
  17. DEFA14A Proxy Proxy Materials
  18. DEF 14A Proxy Proxy Statement
  19. 8-K Event Executive or director change · Regulation FD disclosure
  20. S-3ASR Offering Registration Statement

Page 7 of 33 · 660 filings